Skip to content
Disease
Innovation
Therapy
Pubs & Podiums
About
About OcuDyne
Leadership
In the News
Collaborators
Careers
Contact Us
First Study
February 2021
Enrollment finally reopens in Melbourne, Australia for the OC-1901 study!
Posts navigation
Previous Article:
COVID Impact
Next Article:
First Patient
